Jessica Snow - 01 Jul 2024 Form 4 Insider Report for 2seventy bio, Inc. (TSVT)

Role
Title: Senior Vice President of Quality and Enabling Functions
Signature
/s/ Iya Kessler, Attorney-in-Fact
Issuer symbol
TSVT
Transactions as of
01 Jul 2024
Net transactions value
-$56.25
Form type
4
Filing time
03 Jul 2024, 16:14:50 UTC
Previous filing
05 Jun 2024
Next filing
16 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TSVT Common Stock Award $0 +108,538 +195% $0.000000 164,160 01 Jul 2024 Direct F1
transaction TSVT Common Stock Sale $56.25 -14 -0.01% $4.02 164,146 02 Jul 2024 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This restricted stock unit award vests ratably over a two-year period in annual installments with the first installment vesting on July 1, 2025, subject to the Reporting Person's continued service through the applicable vesting date.
F2 Shares were sold to cover tax withholding obligations incurred in connection with the vesting of restricted stock units.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.00 to $4.02, inclusive. The Reporting Person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Remarks:

Title: Senior Vice President of Quality and Enabling Functions